ClinicalTrials.govpublic full text
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
diabetes mellitus, type 2, hypertension, canagliflozin, jnj 28431754, sodium-glucose transporter 2, blood glucose, type 2 diabetes mellitus, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856934
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.